Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology

The Galleri Assay

SYMPLIFY — Department of Oncology

Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study - The Lancet

The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit

Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up, Breast Cancer Research

Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - ScienceDirect

A spectroscopic liquid biopsy for the earlier detection of multiple cancer types

Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK - The Lancet Oncology

Cancers, Free Full-Text

Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study - The Lancet

Modelled mortality benefits of multi-cancer early detection screening in England

Multicancer blood test shows efficacy for early cancer detection

Jason Carey on LinkedIn: Black History Month

Jeffrey Venstrom, M.D. on LinkedIn: #esmo22